Berkshire Hathaway and Warren Buffett now own more than 14% of the company stock in DaVita Inc., a kidney dialysis firm.
In a filing this past Thursday with the Securities and Exchange Commission, Berkshire Hathaway let us know that they now own a total of 13.6 million shares of the company based out of Denver.
At the end of last year, when Berkshire Hathaway first disclosed information about their investment in DaVita, it only owned a total of 2.7 million shares at that time. In the beginning of this past October, Berkshire Hathaway only had around 10 million shares.
Very typically, the officials at Berkshire Hathaway do not comment or discuss the SEC filings. So we do not know if this is an investment specifically from Warren Buffett, or if it comes from one of his investment managers currently sharing some of the stock picking burden with Warren Buffett.
Last week, Berkshire Hathaway bought a total of 635,633 shares of the company at a price range between the amounts of $104.58 and $107.38.
At the time of this writing, DaVita currently runs about 2000 outpatient dialysis clinics.